Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies
Sarah Kanbour, Adrian S. Dobs
Abstract
Sarah Kanbour, Adrian S. Dobs
Abstract
Polycystic ovary syndrome (PCOS) is an essential differential diagnosis of hyperandrogenism to consider in women, with most women presenting with irregular menses, infertility, and hirsutism. The diagnosis is challenging because it is a heterogenous disorder with significant variations in its associated features. Classic PCOS (hyperandrogenism plus ovulatory dysfunction) affects about 10% of reproductive-age women. Hyperandrogenism (clinical, biochemical, or both) is a hallmark of the syndrome. Approximately 60–76% of PCOS women are hirsute and hyperandrogenemia is observed in 75–90% of these women. Androgen assays are not always reliable at the lower levels detected in women with PCOS. This article will attempt to review the pathophysiology and controversies of hyperandrogenism in PCOS women, its clinical and biochemical presentations, and management.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Polycystic ovary syndrome (PCOS) is an essential differential diagnosis of hyperandrogenism to consider in women, with most women presenting with irregular menses, infertility, and hirsutism. The diagnosis is challenging because it is a heterogenous disorder with significant variations in its associated features. Classic PCOS (hyperandrogenism plus ovulatory dysfunction) affects about 10% of reproductive-age women. Hyperandrogenism (clinical, biochemical, or both) is a hallmark of the syndrome. Approximately 60–76% of PCOS women are hirsute and hyperandrogenemia is observed in 75–90% of these women. Androgen assays are not always reliable at the lower levels detected in women with PCOS. This article will attempt to review the pathophysiology and controversies of hyperandrogenism in PCOS women, its clinical and biochemical presentations, and management.
Key concepts: Hyperandrogenism, hirsutism, Polycystic ovary, Infertility, Medicine, Androgen Excess, Gynecology, Pathophysiology